Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

Bibliographic Details
Main Authors:	Emmanouil Rampakakis, Majed Khraishi, Maqbool Sheriff, Dalton Sholter, Allen J Lehman, François Nantel, Regan Arendse
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-08-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/8/e036245.full

Similar Items

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-09-01)

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-11-01)

Golimumab for the treatment of psoriatic arthritis
by: H Yang, et al.
Published: (2011-05-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

Ustekinumab for the treatment of psoriatic arthritis: an update
by: Davari P, et al.
Published: (2014-09-01)

Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020-03-01)

The use of ustekinumab in refractory treatment of psoriatic arthritis
by: Vega Villanueva, Karen, et al.
Published: (2014)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
by: Melissa A Michelon, et al.
Published: (2010-05-01)

Ustekinumab is a new drug to treat psoriasis and psoriatic arthritis
by: Yuliya Leonidovna Korsakova, et al.
Published: (2013-04-01)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
by: Montepaone M, et al.
Published: (2014-02-01)

Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
by: Soledad Venegas-Iribarren, et al.
Published: (2018-04-01)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
by: Monika Hebeisen, et al.
Published: (2019-01-01)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018-07-01)

Infliximab no tratamento da artrite psoriásica grave Infliximab in treatment of severe psoriatic arthritis
by: Adriano Jaime Consorte Loyola, et al.
Published: (2005-10-01)

Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis
by: T. V. Korotaeva, et al.
Published: (2015-06-01)

CLINICAL EXPERIENCE WITH USTEKINUMAB IN THE TREATMENT OF EARLY PSORIATIC ARTHRITIS USING TREAT-TO-TARGET STRATEGY
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

Golimumab for Rheumatoid Arthritis
by: Eleftherios Pelechas, et al.
Published: (2019-03-01)

Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice
by: Yu. L. Korsakova, et al.
Published: (2021-01-01)

New-onset vitiligo as an unusual cutaneous reaction under ustekinumab therapy in patients with psoriatic arthritis
by: Onur Kaan Gedikli, et al.
Published: (2020-10-01)

Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
by: Karla R. Castro, et al.
Published: (2011-01-01)

Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis
by: Yuki Matsuura-Otsuki, et al.
Published: (2017-05-01)

Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis
by: Richard Hariman, et al.
Published: (2016-01-01)

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis
by: Jeffrey R. Curtis, et al.
Published: (2019-12-01)

Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy
by: Anna Lis-Święty, et al.
Published: (2015-10-01)

A Case of Phlegmonous Gastritis in a Patient with Psoriatic Arthritis on Infliximab
by: Laurence De Davide, et al.
Published: (2018-01-01)

The comparison of effectiveness of therapy with ustekinumab and etanercept in psoriatic patients during 48 weeks’ observation
by: Dominika Wcisło-Dziadecka, et al.
Published: (2021-03-01)

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland
by: Pawel Petryszyn, et al.
Published: (2020-08-01)

RESULTS OF USTEKINUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION ACCORDING TO THE DATA OF PSUMMIT 1 AND PSUMMIT 2
by: Yu. L. Korsakova, et al.
Published: (2015-04-01)

Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis
by: A. Minosi, et al.
Published: (2011-06-01)

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
by: N Woolacott, et al.
Published: (2006-09-01)

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis
by: Svedbom A, et al.
Published: (2017-04-01)

Paradoxical flare of psoriasis, psoriatic spondyloarthritis, and psoriatic uveitis after switching from infliximab to secukinumab
by: Peiqi Su, et al.
Published: (2017-06-01)

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
by: M Rodgers, et al.
Published: (2011-02-01)

Ustekinumab successfully treated a patient with severe psoriasis vulgaris with primary failure to infliximab and secondary failure to adalimumab
by: Chiharu Tateishi,, et al.
Published: (2015-07-01)

Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/ Spondyloarthritis Registry
by: Blachley, T., et al.
Published: (2022)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
by: Ellis LA, et al.
Published: (2019-01-01)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-03-01)